Patrick Loustau
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Patrick Loustau
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 74 | |
| Public Company | Pharmaceuticals: Major | 67 | |
| Extinct | Biotechnology | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Patrick Loustau tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member President | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chief Operating Officer Chief Executive Officer Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MEAD JOHNSON NUTRITION CO | Food: Meat/Fish/Dairy | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| University of Virginia | College/University | Undergraduate Degree Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | President Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Glasgow | College/University | Doctorate Degree Doctorate Degree | |
| The College of William & Mary | College/University | Undergraduate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
| The University of Texas at Austin | College/University | Doctorate Degree Doctorate Degree | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Masters Business Admin | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| University of Aarhus | College/University | Graduate Degree Graduate Degree | |
| Technical University of Denmark | College/University | Chairman Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Indian Institute of Technology Roorkee | College/University | Graduate Degree Undergraduate Degree | |
NNE A/S
 NNE A/S Engineering & ConstructionIndustrial Services Part of Novo Nordisk A/S, NNE A/S is a Danish company that supplies systems, consultancy and engineering services. The company is based in Soborg, Denmark. | Engineering & Construction | Director/Board Member Chairman | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO Director/Board Member | |
| Bristol-Myers Squibb Foundation | Director/Board Member Director/Board Member | ||
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Director/Board Member Chairman Director/Board Member | |
| The University of Texas Southwestern Medical Center | College/University | Corporate Officer/Principal Doctorate Degree | |
| NNIT A/S | Information Technology Services | Director/Board Member Chairman Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Novo Nordisk Region Europe A/S
 Novo Nordisk Region Europe A/S Financial ConglomeratesFinance Novo Nordisk Region Europe A/S holds ownership interests in other companies to undertake investment and financing activities. It offers service on an operational basis, including the placement of capital in companies and real estate. The company was founded September 14, 2001 and is headquartered in Bagsvaerd, Denmark. | Financial Conglomerates | Chairman Chairman | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| St Bartholomew's Hospital Medical College | College/University | Doctorate Degree Graduate Degree | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| CATALENT, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| ARVINAS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director of Finance/CFO Chairman Director/Board Member Corporate Officer/Principal | |
| GOSSAMER BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Asylia Therapeutics, Inc.
 Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Medical/Nursing Services | Director/Board Member Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 31 |
| Danimarca | 13 |
| Regno Unito | 4 |
| Israele | 2 |
| Francia | 2 |
Settori
| Health Technology | 25 |
| Consumer Services | 15 |
| Finance | 4 |
| Commercial Services | 2 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 495 |
| Corporate Officer/Principal | 287 |
| Independent Dir/Board Member | 154 |
| Chairman | 134 |
| Chief Tech/Sci/R&D Officer | 103 |
Contatti più connessi
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Göran Albert Ando | 44 |
| Jack Nielsen | 38 |
| Thomas Daniel | 35 |
| Sten Scheibye | 31 |
| Robert Perez | 31 |
| Dinesh C. Paliwal | 31 |
| Jesper Brandgaard | 28 |
| Peter Helt Jacobsen Haahr | 21 |
| Frances K. Heller | 21 |
| Leif Valdemar Johansson | 21 |
| Sheila Gujrathi | 20 |
| Hannu Ragnvald Ryöppönen | 20 |
| Thomas Lynch | 20 |
| Charles Sigal | 20 |
- Borsa valori
- Insiders
- Patrick Loustau
- Connessioni Società
